Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice

被引：0
|
作者：
S Reuter
P Braken
B Jensen
S Sierra-Aragon
M Oette
M Balduin
R Kaiser
D Häussinger
机构：
[1] University Hospital,Clinic for Gastroenterology, Hepatology and Infectious Diseases
[2] University Hospital of Cologne,Institute of Virology
[3] Hospital Augustinerinnen,undefined
来源：
European Journal of Medical Research | / 15卷
关键词：
CCR-5; CXCR-4; salvage; genotype; resistance testing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MARAVIROC IN TREATMENT-EXPERIENCED PATIENTS WITH HIV-1 INFECTION - EXPERIENCE FROM ROUTINE CLINICAL PRACTICE
    Reuter, S.
    Braken, P.
    Jensen, B.
    Sierra-Aragon, S.
    Oette, M.
    Balduin, M.
    Kaiser, R.
    Haeussinger, D.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (06) : 231 - 237
  • [2] Darunavir: In treatment-experienced pediatric patients with HIV-1 infection
    McKeage K.
    Scott L.J.
    [J]. Pediatric Drugs, 2010, 12 (2) : 123 - 131
  • [3] Antiretroviral regimens for treatment-experienced patients with HIV-1 infection
    Lagnese, Meena
    Daar, Eric S.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (05) : 687 - 700
  • [4] PHARMACOECONOMIC ANALYSIS OF MARAVIROC IN TREATMENT-EXPERIENCED HIV PATIENTS IN BRAZIL
    Machado, M.
    Canella, M.
    Franco, E.
    Zajdenverg, R.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A119 - A119
  • [5] Safety and efficacy of dolutegravir and maraviroc plus background regimen in HIV-1 treatment-experienced participants
    Prakash, M.
    Huang, J.
    Lim, J.
    Koteff, J.
    Trezza, C.
    Griffith, S.
    Ait-Khaled, M.
    Wynne, B.
    Gartland, M.
    Clark, A.
    Aboud, M.
    [J]. HIV MEDICINE, 2016, 17 : 21 - 21
  • [6] EtravirineA Review of its Use in the Management of Treatment-Experienced Patients with HIV-1 Infection
    Jamie D. Croxtall
    [J]. Drugs, 2012, 72 : 847 - 869
  • [7] Deep Sequencing to Infer HIV-1 Co-Receptor Usage: Application to Three Clinical Trials of Maraviroc in Treatment-Experienced Patients
    Swenson, Luke C.
    Mo, Theresa
    Dong, Winnie W. Y.
    Zhong, Xiaoyin
    Woods, Conan K.
    Jensen, Mark A.
    Thielen, Alexander
    Chapman, Douglass
    Lewis, Marilyn
    James, Ian
    Heera, Jayvant
    Valdez, Hernan
    Harrigan, P. Richard
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (02): : 237 - 245
  • [8] Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection
    Kuemmerle, Tim
    Lehmann, Clara
    Hartmann, Pia
    Wyen, Christoph
    Faetkenheuer, Gerd
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1773 - 1785
  • [9] Etravirine A Review of its Use in the Management of Treatment-Experienced Patients with HIV-1 Infection
    Croxtall, Jamie D.
    [J]. DRUGS, 2012, 72 (06) : 847 - 869
  • [10] Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1
    Giaquinto, Carlo
    Mawela, Muthuhadini Patience
    Chokephaibulkit, Kulkanya
    Della Negra, Marinella
    Mitha, Ismail Haroon
    Fourie, Jan
    Fang, Annie
    van der Ryst, Elna
    Valluri, Srinivas Rao
    Vourvahis, Manoli
    Zhang-Roper, Rebecca Yanhui
    Craig, Charles
    McFadyen, Lynn
    Clark, Andrew
    Heera, Jayvant
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (05) : 459 - 465
12345